← Open Payments lookup

MICHELLE BLACKSTON: Open Payments

NPI 1194277152 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,357 in 62 payments from 15 companies in 2025. Trend: 2023 $1,114 · 2024 $1,794 · 2025 $1,357

Food & beverage: $1,357
CompanyPaymentsAmount
Alkermes, Inc.8$236
Axsome Therapeutics, Inc.5$177
Otsuka America Pharmaceutical, Inc.7$169
ABBVIE INC.10$148
Lundbeck LLC10$137
Vanda Pharmaceuticals Inc.5$90
Almatica Pharma LLC3$88
E.R. Squibb & Sons, L.L.C.3$71
Tris Pharma Inc3$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46

Products named: REXULTI, Auvelity, VRAYLAR, LYBALVI, HETLIOZ, LOREEV XR, COBENFY, Dyanavel XR.

Industry payments across MD — which companies pay providers there.